Registration - Consultant

Glaxosmithkline / Kate Moseley-Williams, Consultant

Registration Information

Client name: Glaxosmithkline
Lobbyist name: Kate Moseley-Williams, Consultant
Initial registration start date: 2019-01-29
Registration status: Inactive
Registration Number: 942204-363846

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 1 of 1 (2019-01-29 to 2019-07-16)

Lobbying Information

Subject Matters

Constitutional Issues
Economic Development
Health
Science and Technology

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program

Proposed changes under the Patent Act pertaining to regulations on patented medicines, which regulates the PMPRB.

Policies or Program

Patented Medicines Review Board (PMPRB), certified under the Patent Act and whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Specifically with regard to ensuring that any actions and proposed changes by the PMPRB are consistent with the mandate assigned by Parliament.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Health Canada (HC)
Innovation, Science and Economic Development Canada (ISED)
Treasury Board Of Canada Secretariat (TBS)

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
7333 Mississauga Road North
Mississauga, ON L5N 6L4
Canada

Telephone number: 416-574-5014

Client representative

Ryan Lock, Lead-Federal Affairs and Public Policy

Parent Company Information

GlaxoSmithKline Finance plc
- 980 Great West Road
  Brentford TW89GS
  United Kingdom

Coalition Members Information

Glaxosmithkline is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Glaxosmithkline are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Glaxosmithkline does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Kate Moseley-Williams | No public offices held

Business address:
264 Adelaide St. E, Suite 200
Toronto, ON M5A 1N1
Canada

Telephone number: 416-645-2912

Consultant Firm and Address

Firm: Crestview Strategy

Address:
264 Adelaide St. E, Suite 200
Toronto, ON M5A 1N1
Canada

Telephone number: 416-645-2912

Glaxosmithkline/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Glaxosmithkline/	2019-01-29	2019-07-16

Glaxosmithkline

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Glaxosmithkline / Kate Moseley-Williams, Consultant

Registration Information

Associated Communications

Version 1 of 1 (2019-01-29 to 2019-07-16)

Version 1 of 1 (2019-01-29 to 2019-07-16)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program

Policies or Program

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address

Registration - Consultant

Glaxosmithkline / Kate Moseley-Williams, Consultant

Version 1 of 1 (2019-01-29 to 2019-07-16)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program

Policies or Program

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address

Glaxosmithkline/

The following names have been used on or after July 2, 2008

Glaxosmithkline

Kate Moseley-Williams, Crestview Strategy (Consultant)